Patent ID: 11913958
Assignee: ECS-PROGASTRIN SA
Field: Pharmaceuticals (Chemistry)
Classification: CPC G  A  C | IPC A  C  G

Claim 0:
1. A method for the in vitro diagnosis of lung cancer in a subject, said method comprising:
a) obtaining a biological sample from said subject,
b) detecting whether progastrin is present in said biological sample by contacting said biological sample with at least one progastrin-binding molecule, wherein said progastrin-binding molecule is a monoclonal antibody produced by the hybridoma deposited at the CNCM, Institut Pasteur, 25-28 rue du Docteur Roux, 75724 Paris CEDEX 15, France, on 27 Dec. 2016, under reference 1-5158,
c) detecting the binding of said progastrin-binding molecule to progastrin in said biological sample,
d) detecting whether a lung cancer biomarker is present in said biological sample, and
e) diagnosing said subject with a lung cancer when the presence of progastrin and said lung cancer biomarker is detected.